chimeric antibody drugs
Shirley, NY 11967, USA, New York, 11967
Since the advent of chimeric recombinant antibody technology in 1984, several chimeric antibody drugs have been approved by Food and Drug Administration, including Infliximab, Cetuximab, Abciximab, etc., all of which were IgG isotypes and have made great devotion to the diagnosis and treatment of inflammation, autoimmune diseases, and tumors.
5 out of 5 from 1 reviews